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ABSTRACT 
Two new neolignans, madangones A (1) and B (2), together with (+)-kunstlerone (3), vanillin, 
vanillic acid, betulin, β-sitosterol and β-sitostenone, were isolated from the stem bark of 
Beilschmiedia madang (Lauraceae). The structures of the compounds were determined by 
spectroscopic means. The compounds were tested for antioxidant, acetylcholinesterase 
inhibitory and anti-inflammatory activities. Compound (3) displayed the strongest DPPH 
radical-scavenging activity with an IC50 value of 68.7 µM. Compound (2) exhibited the highest 
level of activity on the COX-2 model and acetylcholinesterase inhibition assay, with IC50 











 The pantropical genus Beilschmiedia Nees of the family Lauraceae comprises about 250 
species, distributed mainly in tropical regions of Asia and Africa. Most of these species grow 
in tropical climate, and are widespread in tropical Asia, Africa, Australia, New Zealand, Central 
America, Carribean Islands and South America (Nishida, 1999). This genus produces alkaloids, 
endiandric acid derivatives, essential oils, fatty acids, epoxyfuranoid lignans, flavonoids and 
terpenoids, and many of these compounds possess antioxidant, antibacterial, antimalarial and 
anti-tuberculosis activities (Chen et al., 2007; Lenta et al., 2009; Chouna et al., 2010). A few 
species of this genus are used in traditional medicines for the treatment of various diseases. For 
example, the stem bark of B. anacardioides is used in Cameroon  to treat uterine tumours, 
rubella, rheumatisms, bacterial and fungal infections, while the seeds are used as spices 
(Tchoula, 2001); B. manii is used to treat dysentery and  headache, and also as an appetite 
stimulant (Iwu, 1993); the stem bark of B. pahangensis is used in a drink usually given after 
childbirth and also for stomach pains and diarrhoea;  the leaves of B. tonkinensis are used by 
Indonesians and Malays to make poultices for application on the broken bones (Wiart, 2006).  
 Beilschmiedia madang is commonly known as ‘medang merah’ or ‘lahu’ in Malaysia. It 
grows in primary, secondary or mixed dipterocarp forest, and on sandy loam soils in Malaysia 
and Indonesia (Nishida, 2008). Dehatrine, a bisbenzylisoquinoline alkaloid, was isolated 
previously from B. madang and found to have antimalarial activity (Kitagawa et al., 1993). The 
chemical compositions and biological activities of the leaf and bark oils from B. madang have 
been reported recently (Salleh et al., 2015a). The bark oil showed significant β-
carotene/linoleic acid bleaching (90.3%) and DPPH radical-scavenging (IC50 212.0 µg/mL) 
activities, and strong antifungal propertiy against Aspergillus niger and A. fumigatus (MIC 62.5 
µg/mL). The leaf oil also displayed significant inhibition of acetylcholinesterase (55.2%), 
butyrylcholinesterase (60.4%) and antityrosinase (53.1%) activities (Salleh et al., 2014). In 
continuation of our phytochemical and bioactivity studies on this genus (Salleh et al., 2015a,b), 
herein we report the isolation, identification and bioactivities (antioxidant, acetylcholinesterase 
inhibitory and anti-inflammatory) of compounds from the stem bark of B. madang (Fig. 1). 
 
2. Results and discussion 
 Compound (1) was obtained as a white amorphous solid, [∝]20
𝐷𝐷
 = +0.29. The EIMS 
spectrum revealed the molecular ion peak [M]+ at m/z 386 corresponding to the molecular 
formula C22H26O6. The IR spectrum revealed absorption bands at 1699 and 1595 cm-1 for 
carbonyl and olefinic stretching vibrations, respectively (Rossi, 1997). The 1H NMR spectrum 
(Table 1) established the presence of three ABX type phenyl protons at δH 6.83 (1H, d, J = 8.0 
Hz, H-5′), 6.82 (1H, dd, J = 8.0 and 1.6 Hz, H-6′), and 6.92 (1H, d, J = 1.6 Hz, H-2′), four 
methoxyl groups at δH 4.13, 3.92, 3.88, and 3.74, and protons of a propenyl group H-10 (δH 
2.42, m), H-11 (δH 5.70, m) and H-12 (δH 5.13, d, Jtrans = 16.0 Hz/δH 5.17, d, Jcis = 10.4 Hz). 
The proton at C-7 of the cyclobutane moiety in compound (1) (Fig. 1) produced a doublet of 
doublets at δH 3.30 with coupling constants of J = 8.4 and 7.6 Hz, which indicated that it was 
trans to H-8 (δH 2.92) and H-6 (δH 2.96, d, J = 8.4 Hz). The COSY spectrum (Table 1) 
displayed coupling between olefinic protons, H-12 with H-11 along with cross peaks of proton 
H-7 with H-6 and H-8. In addition, protons of H-10 also produced cross peak with the olefinic 
proton H-11. The 13C NMR spectrum (Table 1) showed the presence of 22 signals and the 
DEPT spectra characterized them as seven quaternary, eight methines, three methylenes, and 
four methoxyl carbons. The HMQC spectrum exhibited direct connectivities (1J coupling) of 
all protons with associated carbons, e.g., H-7  to C-7 (δC 44.2), H-8 to C-8 (δC 49.1), and H-9 
to C-9 (δC 70.8), and thus confirmed the assignment of all 1H and 13C NMR signals 
corresponfing to methine, methylene, and methoxyl groups. The HMBC spectrum (Table 1) 
displayed cross peak between H-10 with C-11/C-6/C-8/C-1, while H-9 was observed to 
correlate with C-1/C-6/C-7/C-8. Compound (1) and (3) showed similar 1H and 13C NMR 
profiles except the methylenedioxygroup at C-3 and C-4 in (3) are replaced by two methoxyl 
groups in (1). These assignments were further confirmed by HMQC which displayed 
correlations between methoxyl proton signals at δH 3.92 (H-3′) and 3.88 (H-4′) with carbon 
signals at δC 56.0 (C-3′) and 55.9 (C-4′). The HMBC spectrum (Table 1) displayed, among the 
key 1H-13C long-range correlations, 3J correlations from H-10 to C-6 (δC 50.0), C-8 (δC 49.1), 
and 2J to C-1 (δC 45.9) and C-11 (δC 132.0), while H-9 was observed to correlate 3J with C-1 
(δC 45.9), C-2 (δC 79.1) and C-7 (δC 44.5), and  2J with C-8 (δC 49.5), and a zig-zag 4J coupling 
to C-6 (δC 50.0). In the NOESY spectrum, among the nOes, the key nOe correlations were 
between H-6/H-8, H-2/3-OCH3, H-6/H-10, and H-7/H-9. Thus, based on the NOESY spectrum 
and comparison of its optical rotation with that of the known compound (3) (Eagler et al., 1994; 
Mollataghi et al., 2011), the relative configuration of the five stereogenic centers in compound 
(1) were assigned as 7R, 8R, 1R, 6S and 2R. On the basis of the spectroscopic evidence 
discussed above, compound (1) was unequivocally identified as 3,4,3′,4′-tetramethoxy-2,9-
epoxy-6,7-cyclo-1,8-neolign-11-en-5-one, or (+)-madangone A (1), a new furonolignan, from 
B. madang.  
Compound (2) was obtained as a white amorphous solid, [∝]20
𝐷𝐷
 = −0.16. The IR 
spectrum showed the presence of a hydroxyl group at 3466 cm-1, and a highly strained carbonyl 
group at 1738 cm-1. The 1H NMR spectrum of compound (2) (Table 1) displayed similar signal 
patterns as observed in the 1H NMR spectrum of compound (1), e.g., the presence of ABX type 
phenyl protons (H-5′/H-6′/H-2′), and protons of the cyclobutane group (H-5/H-6/H-7). The 
spectrum also showed the presence of two equivalent methylene protons H-8 at δH 3.68 (2H, 
dd, J = 13.2, 8.4 Hz). Clearly, the signals for four methoxyl groups as found in the 1H NMR 
spectrum of compound (1) (Table 1) were absent in the 1H NMR spectrum of compound (2). 
Instead, a 1H singlet signal at δH 6.55 could be attributed to H-3, and a sharp 2H singlet at δH 
5.97 was characteristic for a methylenedioxy functionality linked to the phenyl ring in 
compound (2) (Fig. 1). Cross peaks between methylene protons of H-11 (δH 5.12 and 5.15) and 
H-10 (δH 5.76) along with H-8 (δH 3.66 and 3.68) with H-7 (δH 2.69) were observed in the 
COSY spectrum (Table 1). The 13C NMR, DEPT and HMQC spectra exhibited eighteen 
carbon, assigned for six quaternary, eight methine, and four methylene carbons (one of them 
was a characteristic methylenedioxy signal). The HMBC spectrum (Table 1) revealed 
connectivities of proton H-5 and H-6 with C-1/C-6/C-7/C-8/C-9. Proton H-8 was found to 
correlate with C-6/C-7/C-9/C-1, but there was no correlation observed between H-8 and C-2 
(as it was present in compound 1). The HMBC experiment also showed H-3 (δH 6.55) 
correlating (2J) with the carbonyl group at C-4 (δC 203.4). Comparing the spectroscopic data 
and optical rotation data of compound (2) with related compounds published in the literature 
(Mollataghi et al., 2011), the relative configurations at the stereogenic centres in compound (2) 
were assigned as 6R and 7S. The above data were in complete agreement with the EIMS 
spectrum which exhibited the molecular ion peak at m/z 314 corresponding to the molecular 
formula C18H18O5. Thus, compound (2) was identified as 2,8-dihydroxy-3′,4′-methylenedioxy-
5,6-cyclo-1,7-neolign-10-en-4-one, or (-)-madangone B (2). All known compounds, vanilin, 
vanillic acid, betulin (Lin et al., 2010), β-sitosterol (Huang et al., 2011) and β-sitostenone (Lin 
et al., 2009), were identified by comparison of their spectroscopic data with literature data. The 
plants of the Lauraceae tend to produce alkaloids and lignans/neolignans, but generally not 
both groups of compounds in a single plant. However, there are also examples of plants of this 
family (including Beilschmiedia madang) where alkaloids and lignans/neolignans coexist. 
Because of this, it is somewhat difficult to draw any conclusive chemotaxonomic inference just 
on the basis of the presence or absence of alkaloids or lignans/neolignans in the species of the 
genus  Beilschmiedia or the family Lauraceae. 
Several biological activities of lignans and neolignans, e.g., cytotoxic, antitumor, 
antileukaemia, antiviral, antimicrobial, anti-inflammatory, anti-allergy, as well as antifungal, 
insecticidal and miscellaneous physiological effects, have been reported to date (MacRae and 
Towers, 1984; Whiting, 1987). The neolignans (1-3), isolated in this study, were tested for their 
antioxidant, acetylcholinesterase inhibitory and anti-inflammatory activities. The results are 
showed in Table 2. The antioxidant activity was evaluated by using the DPPH free-radical-
scavenging with a series of different concentrations. Compounds (1) and (3) showed a strong 
antioxidant activity comparable to that of ascorbic acid with IC50 the values of 73.5 and 68.7 
µM. Previous study on compound (3) has showed a potent antioxidant activity (Mollataghi et 
al., 2011). The compounds were screened for AChE inhibitory activity using the Ellman’s 
colorimetric method in a 96-well plate. Compound (2) had better activity than that of compound 
(1) against AChE with an IC50 value of 70.3 µM.  It can be noted that in a previous study, the 
bark oil showed DPPH radical-scavenging (IC50 212.0 µg/mL) activity, and the leaf oil 
inhibited acetylcholinesterase (55.2%) (Salleh et al., 2014). Both these activities, as observed 
with the purified compounds (1-3) in the present study, have further confirned the potential 
bioactivities of this plant.  
In the COX-2 assay, compound (1) furnished strong activity with an IC50 value of 59.4 
µM.  The IC50 value for indomethacin, used as a positive control, was 21.3 µM. The chemistry 
of the Lauraceae family is recognized by the presence of neolignans, which are known to 
possess anti-inflammatory activity through suppression of tumour necrosis factor (TNF)-α and 
nitric oxide (NO) production (Cho et al., 2000) and inhibitory activity against the two isozymes 
of COX- 2 (Su et al, 2002). These results imply that the neolignans isolated from B. madang 
might be beneficial in the treatment of Alzheimer and vascular diseases, predominantly caused 
by oxidative cell damages. 
 
3. Experimental 
3.1. General experimental procedures 
 The optical rotations were recorded on a Perkin Elmer 341 Polarimeter equipped with a 
sodium lamp and chloroform as solvent. The mass spectra were recorded on Bruker Mass 
Spectrometry, obtained from the National University of Singapore (NUS). The UV spectra 
were obtained in methanol on a Shimadzu UV 1601PC spectrophotometer. The IR spectra were 
obtained on a Perkin-Elmer 1600 FTIR spectrophotometer. The 1D and 2D NMR spectra were 
recorded in deuterated chloroform on a Bruker Avance 400 MHz spectrometer, chemical shifts 
(δ) are reported in ppm on δ scale, and the coupling constants (J) are given in Hz. Column 
chromatography was carried out on silica gel 70-230 mesh (Merck). Silica gel 60 F254 precoated 
aluminium plates (0.2 mm, Merck) were used for TLC analysis. The TLC and PTLC spots 
were visualized under UV light (254 and 366 nm) followed by spraying with 5% H2SO4 and 
1% vanillin in MeOH and heating at 120°C for 5 min. All solvents were AR grade. 
3.2. Plant material 
 The stem bark of Beilschmiedia madang Blume was collected from Hutan Simpan Bangi, 
Selangor, Malaysia, in September 2012. The species was identified by Dr. Shamsul Khamis 
from Institute of Bioscience, Universiti Putra Malaysia and a voucher specimen, SK1984/2012 
was deposited at the Herbarium of IBS, UPM. 
3.3. Extraction and isolation 
 Cold extraction of the powdered stem bark (3 kg) of B. Madang, sequentially, with n-
hexane, EtOAc and MeOH yielded the crude extracts, n-hexane (BMBH: 14.5 g, 0.7%), EtOAc 
(BMBE: 26.2 g, 1.3%) and MeOH (BMBM: 28.1 g, 1.4%). The EtOAc extract (10.0 g) was 
fractionated by VLC on silica gel, eluting with n-hexane:CHCl3:EtOAc to afford 15 major 
fractions (BMBE1-15). Fractions BMBE2-6 and BMBE10-15 were purified by CC on silica 
gel to obtain compounds (1) (344.0 mg) and (2) (34.4 mg), respectively. Similar VLC (on silica 
gel) purification of the n-hexane extract (10.0 g) eluting with n-hexane:CHCl3:EtOAc afforded 
20 major fractions (BMBH1-20). The combined fractions BMBH15-20 was subjected to 
multiple CC on silica gel to yield compound (3) (462.9 mg). The MeOH extract (BMBM) 
(10.0 g) was subjected to VLC on silica gel eluting with n-hexane:CHCl3:EtOAc to afford 20 
major fractions. Fraction BMBM7-10 was purified by multiple CC on silica gel to yield vanillin 
(25.0 mg) and vanillic acid (15.0 mg). CC (on silica gel) purification of the fractions BMBM2-
4 and BMBM5-6 followed by washing with cold n-hexane produced betulin (10.2 mg), β-
sitostenone (12.8 mg) and β-sitosterol (40.5 mg), respectively.  
 (+)-Madangone A (1): white amorphous solid, [∝]20
𝐷𝐷
 = +0.29 (c 1.2, CHCl3); UVmax 
(MeOH) 231 (1.48) and 285 (1.24) nm; IR (KBr): 3075, 2923, 1699, 1595, 1515, 1463, 1272, 
1116 cm−1; HREIMS m/z 386.1736 (calculated 386.1729 for C22H26O6); 1H-NMR (CDCl3, 400 
MHz), 13C-NMR (CDCl3, 100 MHz), COSY, HMBC and NOESY data see Table 1. 
 (−)-Madangone B (2): white amorphous solid, [∝]20
𝐷𝐷
 = −0.16 (c 0.18, CHCl3); UVmax 
(MeOH) 230 (1.30) and 275 (1.54) nm; IR (KBr): 3466, 3066, 2927, 1738, 1654, 1614, 1490, 
1249, 1038 cm−1; HREIMS m/z 314.1147 (calculated 314.1154 for C18H18O5); 1H-NMR 
(CDCl3, 400 MHz), 13C-NMR (CDCl3, 100 MHz),  COSY and HMBC data see Table 1. 
 (+)-Kunstlerone (3): white amorphous solid; IR (KBr): 3071, 2927, 1727, 1491, 1442, 
1231; 1H- NMR (CDCl3, 400 MHz): δ 2.42 (m, 2H, H-10), 2.86 (dq, 1H, J = 10.8, 6.8 Hz, H-
8), 2.93 (d, IH, J = 8.0 Hz, H-6), 3.25 (dd, 1H, J = 7.6, 7.6 Hz, H-7), 3.77 (dd, 1H, J = 9.6, 3.6 
Hz, H-9), 3.95 (d, 1H, J = 9.6 Hz, H-9), 4.36 (s, 1H, H-2), 5.14 (d, 1H, Jtrans = 16.0 Hz, H-12), 
5.18 (d, 1H, Jcis = 10.4 Hz, H-12), 5.69 (m, 1H, H-11), 6.75 (d, 1H, J = 1.6 Hz, H-6′), 6.77 (d, 
1H, J = 1.6 Hz, H-5′), 6.84 (s, 1H, H-2′); 13C NMR (CDCl3, 100 MHz): δ 41.6 (C-10), 44.5 (C-
7), 45.9 (C-1), 49.5 (C-8), 50.0 (C-6), 58.3 (3-OCH3), 60.4 (4-OCH3), 70.7 (C-9), 79.1 (C-2), 
100.9 (OCH2O), 107.1 (C-2′), 108.2 (C-5′), 119.2 (C-12), 119.5 (C-6′), 132.0 (C-11), 136.4 (C-
1′), 138.4 (C-4), 146.3 (C-4′), 147.9 (C-3′), 159.4 (C-3), 193.0 (C-5); EIMS m/z 370 (M+, 
C21H22O6). 
3.4. Biological activities 
3.4.1. Solvents and chemicals 
 Antioxidant: 1,1-Diphenyl-2-picrylhydrazyl (DPPH), and butylated hydroxytoluene 
(BHT) were obtained from Sigma-Aldrich (Germany). Analytical grade methanol, ethanol and 
dimethylsulfoxide (DMSO) were purchased from Merck (Germany). Acetylcholinesterase: 
AChE enzyme (Type-VI-S, EC3.1.1.7), acetylthiocholine iodide, 5,5′-dithio-bis(2-
nitrobenzoic) acid (DTNB), and galantamine were purchased from Sigma-Aldrich (Germany). 
Anti-inflammatory: Indomethacin and COX Inhibitor Screening Kit (Catalog No 560131) were 
purchased from Cayman Chemical Co. (Ann Arbor, Michigan USA). 
3.4.2. Antioxidant activity 
 The antioxidant activity was determined using DPPH free radical scavenging as 
described previously with minor modifications (Shimada et al., 1992). Briefly, 0.1 mM DPPH 
(1 mL) dissolved in EtOH was added to an EtOH solution (3 mL) of the tested samples at 
different concentrations. An equal volume of EtOH was added in the control test. The mixture 
was shaken vigorously and allowed to stand at room temperature for 30 min. Then the 
absorbance at 517 nm was measured with a UV–vis spectrophotometer. The percentage of 
scavenging of DPPH was calculated using the following equation:  
I% = [ Ablank – Asample / Ablank ] × 100; 
where Ablank is the absorbance value of the control reaction (containing all reagents except the 
test compound) and Asample is the absorbance value of the test compound. The sample 
concentration providing 50% inhibition (IC50) was calculated by plotting inhibition percentages 
against concentrations of the sample. All tests were carried out in triplicate and inhibition 
values were reported as means ± SD of triplicates. 
3.4.3 Acetylcholinesterase (AChE) inhibitory activity 
 AChE inhibitory activity of the compounds was measured by slightly modifying the 
spectrophotometric method (Ellman et al., 1961; Salleh et al., 2015). Electric eel AChE was 
used, while acetylthiocholine iodide (AChI) was employed as the substrate of the reaction. 
DTNB  acid was used for the measurement of the AChE activity. Briefly, 140 µL of sodium 
phosphate buffer (pH 8.0), 20 µL of DTNB, 20 µL of test compounds and 20 µL of AChE 
solution were added by multichannel automatic pipette in a 96-well microplate and incubated 
for 15 min at 25°C. The reaction was then initiated with the addition of 10 µL of AChI. 
Hydrolysis of AChI was monitored by the formation of the yellow 5-thio-2-nitrobenzoate anion 
as a result of the reaction of DTNB with thiocholines, catalyzed by enzymes at 412 nm utilizing 
a 96-well microplate reader (Epoch Micro-Volume Spectrophotometer, USA). Percentage of 
inhibition (I%) of AChE was determined by comparison of rates of reaction of samples relative 
to blank sample (EtOH in phosphate buffer pH = 8) using the formula: 
I% = [ E – S / E ] × 100; 
where E is the activity of enzyme without test sample and S is the activity of enzyme with test 
sample. The experiments were done in triplicate. Galantamine was used as the positive 
controls. 
3.4.4 Anti-inflammatory activity 
 The anti-inflammatory activity of the compounds on COX-2 was determined by 
measuring prostaglandin E2 (PGE2) using a COX Inhibitor Screening Kit (Catalog No 560131, 
Cayman Chemicals, Ann Arbor Michigan USA) as well as the reported method (Bertanha et 
al., 2012). Reaction mixtures containing the reaction buffer (950 μL), heme (10 μL), COX-2 
(10 μL) and sample/control (20 μL) were incubated at 37°C in a water bath for 15 min. The 
reaction was initiated by addition of arachidonic acid (10 μL) at a final concentration of 100 
μM. After 2 min incubation, the reactions were stopped by addition of 1 M HCl (50 μL), 
followed by saturated solution of stannous chloride (100 μL). Then, prostaglandins (PG) were 
quantified by means of the ELISA method. The contents of the reaction tubes were diluted and 
transferred to a 96-well plate coated with a mouse antirabbit IgG, followed by addition of the 
PG screening acetylcholinesterase tracer and the PG screening antiserum. Plates were 
incubated in an orbital shaker for 18 h, at room temperature. The reaction mixtures were 
removed, and the wells were washed five times with a buffer containing 0.05% Tween 20. 
Acetylthiocholine and 5,5′-dithio-bis-2-nitrobenzoic acid known as Ellman’s reagent (200 μL) 
was then added to each well, and the plate was incubated in an orbital shaker for 60 min, at 
room temperature, until the control wells yielded an optical density lying between 0.3-0.8 at 
415 nm. A standard curve with PG was generated from the same plate, which was used to 
quantify the PG levels produced in the presence of the samples. The compound DuP697 
(Cayman Chemicals) was used to standardize the assay for COX-2 and indomethacin was 
employed as positive control. Results were expressed as a percentage relative to a control 
(100% initial activity, solvent treated samples). All determinations were performed in 
triplicate. Regression analysis was employed for the calculation of IC50 values. 
3.5 Statistical analysis 
Data obtained from biological activities were expressed as mean values. The statistical analyses 
were carried out by employing one way ANOVA (p > 0.05). A statistical package (SPSS 
version 16.0) was used for the data analysis. 
 
Appendix A. Supplementary data 
Supplementary data including 1D/2D NMR, IR, UV and MS for compound (1-2) are available 
as supporting information. 
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